Invest by Design

Medical Innovations Need Science and Capital ft. Kyle Rasbach, PhD, PharmD and Blake Schwarz, DMin

Eventide Asset Management Episode 3

In this episode, Shaun Morgan interviews Dr. Kyle Rasbach to discuss how a background in science and medicine can give investors a distinct advantage when investing in biotechnology companies. We also hear a personal story of the dramatic impact that investing has on real lives.

Follow Eventide on LinkedIn,  Subscribe to our Insights, and learn about our approach at eventideinvestments.com

This podcast is for informational purposes only and expresses the views of the speaker and do not necessarily represent the views of Eventide Asset Management, LLC (“Eventide”), an investment adviser.

This does not constitute individual investment advice nor is it a recommendation or offer to purchase, sell or a solicitation to deal in any security or financial product. Eventide's values-based approach to investing may not produce desired results and could result in underperformance compared with other investments. There is no guarantee that any investment strategy will achieve its objectives, generate profits, or avoid losses. Past performance is no guarantee of future results and the opinions presented cannot be viewed as an indicator of future performance. Mutual fund investors should consider information contained in the prospectus including investment objectives, risks, charges, and expenses.

On any discussion of particular companies are for illustrative purposes only and are not a recommendation, offer to sell, or a solicitation of an offer to buy any security. Eventide clients and investors may maintain positions in the companies discussed in this podcast.

Eventide uses the trademark ("Investing that makes the world rejoice®") in a figurative manner to help explain its focus on serving investors by helping them improve the world. 

Reference to Eventide’s Business 360® approach is provided for illustrative purposes only and indicates a general framework of guiding principles that inform Eventide’s overall research process.  

Third-party sources have not been independently verified, nor is Eventide affiliated with any third-parties referenced, unless otherwise noted. Eventide has not independently verified the accuracy or completeness of third-party information. There can be no assurances that the information is accurate or complete. The information is subject to change without notice.

Eventide does not provide tax, accounting, or legal advice.